Cargando…

SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway

Recent advances in endocrine therapy have improved the prospects for estrogen receptor‐positive breast cancer. Tamoxifen is an effective drug for patients with estrogen receptor‐positive breast cancer, but the development of resistance is common. Therefore, discovering ways to enhance the sensitivit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Jilin, Li, Ji, Fu, Lin, Gai, Junda, Guan, Jingqian, Li, Qingchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853819/ https://www.ncbi.nlm.nih.gov/pubmed/31573734 http://dx.doi.org/10.1002/cam4.2557

Ejemplares similares

SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway
por: Sun, Xiaodan, et al.
Publicado: (2019)

Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: Jiang, Bing, et al.
Publicado: (2021)

FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer
por: Wang, Jinhua, et al.
Publicado: (2016)

Dynamic surveillance of tamoxifen‐resistance in ER‐positive breast cancer by CAIX‐targeted ultrasound imaging
por: Li, Ying, et al.
Publicado: (2020)

Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
por: Yang, Yufei, et al.
Publicado: (2018)

Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl‐CoA acetyltransferase 1
por: Guan, Jingqian, et al.
Publicado: (2020)

Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice
por: Zhang, Zhi, et al.
Publicado: (2021)

Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
por: Jin, Xiaoxia, et al.
Publicado: (2019)

miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2020)

SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis
por: Cao, Yang, et al.
Publicado: (2021)

Paeoniflorin Enhances the Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen through Promoting Sirtuin 4
por: Zhang, Pei, et al.
Publicado: (2022)

The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer
por: Liu, Shu-Shu, et al.
Publicado: (2020)

Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
por: Yin, Li, et al.
Publicado: (2014)

Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer
por: Wang, Ying, et al.
Publicado: (2019)

Although c-MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER-positive breast cancer
por: Chen, Rui, et al.
Publicado: (2020)

Tamoxifen is a candidate first‐in‐class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells—Unrecognized players in tumorigenesis
por: White‐Gilbertson, Shai, et al.
Publicado: (2020)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer
por: Zhu, Ning, et al.
Publicado: (2020)

SIRT3 elicited an anti‐Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis
por: Xu, Lei, et al.
Publicado: (2019)

Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer
por: García-Martínez, José Manuel, et al.
Publicado: (2023)

The pivotal role of DNA methylation in the radio‐sensitivity of tumor radiotherapy
por: Zhu, Xueru, et al.
Publicado: (2018)

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
por: Joseph, James D, et al.
Publicado: (2016)

Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2(+)HR(+) breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis
por: Li, Jia, et al.
Publicado: (2021)

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
por: Joseph, James D, et al.
Publicado: (2019)

Effects of RSF-1 on proliferation and apoptosis of breast cancer cells
por: Liu, Yuhui, et al.
Publicado: (2018)

Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling
por: Wang, Jiaqi, et al.
Publicado: (2020)

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
por: Lv, Qing, et al.
Publicado: (2021)

IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis
por: Rothe, Michael, et al.
Publicado: (2013)

Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating WIF‐1 and suppressing Wnt pathway
por: Zhang, Yun‐Fei, et al.
Publicado: (2020)

LncRNA SNHG16 drives proliferation, migration, and invasion of hemangioma endothelial cell through modulation of miR‐520d‐3p/STAT3 axis
por: Zhao, Wenke, et al.
Publicado: (2018)

Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
por: Wu, Liwei, et al.
Publicado: (2019)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020)

ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
por: Farmaki, Elena, et al.
Publicado: (2023)

Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
por: Gu, Yu, et al.
Publicado: (2016)

Helicobacter pylori‐induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL‐1β expression
por: Wu, Yujiao, et al.
Publicado: (2019)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation
por: He, Lizhi, et al.
Publicado: (2021)

Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2021)

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway
por: Kim, Se Lim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1bfq7f22i5v5p3u8c5p4b7g06m